Suppr超能文献

NF-κB 上调激活素是维持非小细胞肺癌中癌症干细胞样细胞间充质特征所必需的。

Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.

机构信息

Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia.

Department of Pathology, University of Virginia, Charlottesville, Virginia.

出版信息

Cancer Res. 2015 Jan 15;75(2):426-35. doi: 10.1158/0008-5472.CAN-13-2702. Epub 2014 Nov 28.

Abstract

Soluble growth factors and cytokines within the tumor microenvironment aid in the induction of the epithelial-to-mesenchymal transition (EMT). Although EMT promotes the development of cancer-initiating cells (CIC), cellular mechanisms by which cancer cells maintain mesenchymal phenotypes remain poorly understood. Work presented here indicates that induction of EMT stimulates non-small cell lung cancer (NSCLC) to secrete soluble factors that function in an autocrine fashion. Using gene expression profiling of all annotated and predicted secreted gene products, we find that NF-κB activity is required to upregulate INHBA/Activin, a morphogen in the TGFβ superfamily. INHBA is capable of inducing and maintaining mesenchymal phenotypes, including the expression of EMT master-switch regulators and self-renewal factors that sustain CIC phenotypes and promote lung metastasis. Our work demonstrates that INHBA mRNA and protein expression are commonly elevated in primary human NSCLC and provide evidence that INHBA is a critical autocrine factor that maintains mesenchymal properties of CICs to promote metastasis in NSCLC.

摘要

肿瘤微环境中的可溶性生长因子和细胞因子有助于诱导上皮间质转化(EMT)。尽管 EMT 促进了癌症起始细胞(CIC)的发展,但癌细胞维持间充质表型的细胞机制仍知之甚少。这里介绍的工作表明,EMT 的诱导刺激非小细胞肺癌(NSCLC)分泌可溶性因子,以自分泌的方式发挥作用。通过对所有注释和预测的分泌基因产物进行基因表达谱分析,我们发现 NF-κB 活性是上调 TGFβ 超家族中形态发生素 INHBA/Activin 的必需条件。INHBA 能够诱导和维持间充质表型,包括 EMT 主开关调节剂和自我更新因子的表达,这些因子维持 CIC 表型并促进肺转移。我们的工作表明,INHBA mRNA 和蛋白表达在原发性人非小细胞肺癌中普遍升高,并提供证据表明 INHBA 是一种关键的自分泌因子,可维持 CIC 的间充质特性,促进 NSCLC 的转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/4297542/c9343f45c1d5/nihms646245f1.jpg

相似文献

9

引用本文的文献

本文引用的文献

5
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
6
Cancer stem cells niche: a target for novel cancer therapeutics.肿瘤干细胞龛:新型癌症治疗的靶点。
Cancer Treat Rev. 2013 May;39(3):290-6. doi: 10.1016/j.ctrv.2012.10.004. Epub 2012 Dec 5.
9
The bright and the dark sides of activin in wound healing and cancer.激活素在创伤愈合和癌症中的正反两面。
J Cell Sci. 2012 Sep 1;125(Pt 17):3929-37. doi: 10.1242/jcs.094789. Epub 2012 Sep 18.
10
Lung cancer stem cells: tumor biology and clinical implications.肺癌干细胞:肿瘤生物学及临床意义
Asia Pac J Clin Oncol. 2012 Sep;8(3):217-22. doi: 10.1111/j.1743-7563.2012.01550.x. Epub 2012 May 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验